Bile acid secretion during rat liver carcinogenesis

doi:10.1016/S0024-3205(00)00412-4

Life Sciences

Volume 66, Issue 12, 11 February 2000, Pages 1085-1095

https://doi.org/10.1016/S0024-3205(00)00412-4 Get rights and content

Abstract

Retro-differentiation of liver parenchyma during neoplastic processes is characterized by the expression of tumor antigens, such as α-fetoprotein and the placental isoenzyme of glutathione-S-transferase (GST-P). To investigate whether this may also affect a typical liver function such as bile acid secretion was the aim of this work. Rat hepatocarcinogenesis was induced by diethylnitrosamine (i.p., 200 mg/Kg body weight at day 0) and promoted by two-thirds partial hepatectomy (at day 21) plus 2-acetamidofluorene administration (50 mg/Kg body weight, subcutaneously, twice a week from day 14 to day 35). In order to carry out planimetric measurements of neoplastic tissue after immunohistochemical staining, a novel monoclonal antibody (MAb 14.1.3) against GST-P with no cross-reactivity against the major liver isoform of GST (GST-H) was raised. Analysis of total biliary bile acid output using the 3α-hydroxysteroid dehydrogenase method indicated that a significant reduction (−26%) occurred during the formation of GST-P-positive foci (12 wk). This was restored to normal values during adenoma formation (16–20 wk), but decreased again during carcinoma transformation (32 wk). These changes were not parallel to that observed in bile flow, which was progressively but slightly decreased throughout the whole period under study. HPLC analysis of bile samples collected for 1 h at different time points during hepatocarcinogenesis revealed that in contrast to what happens during cholestatic disease, a continuous and progressive increase in the cholic acid-to-chenodeoxycholic acid ratio (from 4.4 ± 0.5 in control animals to 15.1 ± 1.9 in rats with hepatocellular carcinoma) occurs. A significant and transient increase at 16 wk (+120%) in the proportion of bile acids amidated with glycine as compared to those conjugated with taurine was also observed. These results indicate that the mechanisms accounting for the secretion of major bile acids are modified differently at various steps of rat liver tumor development.

References (23)

Z.R. Vlahcevic et al.
Gastroenterology
(1997)
M.J. Monte et al.
Biochim. Biophys. Acta
(1997)
M.J. Monte et al.
J. Hepatol.
(1999)
N.M. Delzenne et al.
Life Sci.
(1994)
J.W. Goding
J. Immunol. Meth.
(1980)
D. Labbe et al.
J. Chromatograph.
(1989)
G.A. Kullak-Ublick et al.
Hepatology
(1996)
G.A. Kullak-Ublick et al.
Gastroenterology
(1997)
Y. Amuro et al.
Int. Hepatol. Com.
(1994)
S. Fukano et al.
Steroids
(1985)

D.W. Russell et al.

Biochemistry

(1992)

Cited by (15)

Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21<sup>WAF1/CIP1</sup> mechanism
2007, Translational Research
Citation Excerpt :
The control group received no treatment. HCC (Hc group) was induced by a modification of the Solt and Farber method,9,28,29 which consisted of diethylnitrosamine i.p. administration (20-mg/100-g body weight) on day 1. From days 14 to 35, animals received 2-acetaminofluorene (5-mg/100-g body weight, subcutaneously twice each week).
The objective of this study was to determine in a rat model of hepatocellular carcinoma (HCC) the effects of the antiangiogenic agent TNP-470 on cell proliferation and effectors of the apoptotic pathway, including p53, p21^WAF1/CIP1, cyclin D, and cyclin E. Tumor was induced in male Wistar rats by diethylnitrosamine and promoted by two-thirds hepatectomy plus acetaminofluorene administration. Experiments were carried out at 28 weeks after initiating the treatment. TNP-470 was administered at 30 mg/kg, 3 times per week from 20 to 28 weeks. Serum levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor beta (HGFβ) liver expression were increased by hepatocarcinogenesis (+38% and +183%, respectively), and treatment with TNP-470 was able to prevent the increase in these angiogenic factors induced by HCC. HCC coursed with reduced expression of p21^WAF1/CIP1 and p53 (−63% and −60%, respectively). Hepatic expression of cyclin D and cyclin E were significantly increased in rats with HCC (+108% and +115%, respectively). In animals with experimental carcinogenesis, a significant increase in the expression of Cdk4 and CdK2 was also observed (+119% and +187%, respectively). These effects were prevented by TNP-470 administration. In conclusion, cell-cycle inhibition by TNP-470 is mediated at least in part by an activation of p21^WAF1/CIP1 because of a p53-dependent mechanism, with reduction of the cyclin D–Cdk4 and cyclin E–Cdk 2 expression. These cytostatic effects should be considered when assessing the efficacy of TNP-470 for anti-angiogenic therapy. These findings may prove useful for the development of therapies for the treatment of human HCC.
Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy
2007, Critical Reviews in Oncology/Hematology
Citation Excerpt :
Cholangiocarcinoma are associated with chronic cholecystitis and gallstone formation, chronic ulcerative colitis, hepatitis C virus and other chronic infections [13,14]. Bile acids may promote carcinogenesis by stimulating a variety of kinase signaling pathways [15–17]. Early stage gallbladder and bile duct cancers may present pathologically as subtle mucosal abnormalities, such as plaque or ulcerations.
Adenocarcinomas of the gallbladder (GBC) and bile ducts (cholangiocarcinoma) (combined as biliary tract cancers, BTC) are uncommon tumors in the United States, but are endemic in parts of South America and Asia. BTC are aggressive tumors with poor survival. Published response rates to chemotherapy are less than 30% and no survival benefit has been demonstrated from palliative systemic therapy. Improved understanding of the biological characteristics and molecular carcinogenic mechanisms of these malignancies may lead to improved therapeutic regimens for patients.
Transient changes in the expression pattern of key enzymes for bile acid synthesis during rat liver regeneration
2005, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Changes in the expression patterns of genes involved in bile acid (BA) synthesis were investigated during rat liver regeneration that follows two-thirds partial hepatectomy. BAs in bile were measured by GC-MS and the absolute and relative abundance of specific mRNAs in the liver by RT-real-time quantitative PCR. Cyclin E mRNA, used as an indicator of liver cell proliferation, peaked at day 1. The levels of mRNA of α-fetoprotein transcription factor (FTF) and small heterodimer partner (SHP) were first reduced (day 1) and then (days 2–3) increased, when those of farnesoid X receptor (FXR) were also transiently enhanced. The early (day 1) up-regulation of Cyp7a1, and Cyp8b1, together with the down-regulation of Cyp27, was consistent with an increased proportion of cholic acid versus chenodeoxycholic acid and a progressive recovery in total BAs secretion. The transient appearance of flat BAs (allo-BAs plus Δ⁴-unsaturated-BAs) during rat liver regeneration was probably due to the changes in the expression ratio of steroid 5α- versus 5β-reductase. Both were first (day 1) down-regulated and then up-regulated (5α-reductase more than 5β-reductase). In conclusion, changes in the expression patterns of nuclear receptors and enzymes involved in BA synthesis are consistent with the transient modifications that occur in BA pool during rat liver regeneration.
Physiological characteristics of allo-cholic acid
2003, Journal of Lipid Research
The physiological characterstics of allo-cholic acid (A91), a typically fetal bile acid that reappears during liver regeneration and carcinogenesis were investigated. [¹⁴C] Tauro-ACA (TACA) uptake by Chinese hamster ovary cells expressing rat organic anion transporter polypeptide (Oatp)1 or sodium-taurocholate cotransporter polypeptide (Ntcp) was lower than that of [¹⁴C]taurocholic acid (TCA). Although TACA inhibited ATP-dependent TCA transport across plasma membrane vesicles from Sf9 cells expressing rat or mouse bile salt export pump (Bsep), no ATP-dependent TACA transport was found. In rats, TACA was secreted into bile with no major biotransformation and it had lower clearance and longer half-life than TCA. In mice, TACA bile output was lower (−50%) than that of TCA, whereas TACA induced 9-fold higher bile flow than TCA. Even though the intracellular levels were lower for TACA, translocation into the hepatocyte nucleus was higher for TACA than for TCA; however, rate of DNA synthesis, expression levels of α-fetoprotein, albumin, Ntcp, and Bsep, cell viability, and apoptosis in rat hepatocytes were similarly affected by both isomers. In conclusion, TACA partly shares hepatocellular uptake system(s) for TCA.
Furthermore, in contrast to other “flat” bile acids, TACA is efficiently secreted into bile via transport system(s) other than Bsep and is highly choleretic, hence its appearance during certain situations may prevent accumulation of cholestatic precursors.
Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic Cancers
2023, Diagnostics
Effects of swim training on liver carcinogenesis in male wistar rats fed a low-fat or high-fat diet
2012, Applied Physiology, Nutrition and Metabolism

View all citing articles on Scopus

View full text

Bile acid secretion during rat liver carcinogenesis

Abstract

Gastroenterology

Biochim. Biophys. Acta

J. Hepatol.

Life Sci.

J. Immunol. Meth.

J. Chromatograph.

Hepatology

Gastroenterology

Int. Hepatol. Com.

Steroids

Biochemistry